Progyny EPS - Earnings per Share 2018-2025 | PGNY
Progyny eps - earnings per share from 2018 to 2025. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Progyny Annual EPS | |
|---|---|
| 2024 | $0.57 |
| 2023 | $0.62 |
| 2022 | $0.30 |
| 2021 | $0.66 |
| 2020 | $0.47 |
| 2019 | $-0.41 |
| 2018 | $0.04 |
| 2017 | $-2.37 |
| Progyny Quarterly EPS | |
|---|---|
| 2025-03-31 | $0.17 |
| 2024-12-31 | $0.12 |
| 2024-09-30 | $0.11 |
| 2024-06-30 | $0.17 |
| 2024-03-31 | $0.17 |
| 2023-12-31 | $0.13 |
| 2023-09-30 | $0.16 |
| 2023-06-30 | $0.15 |
| 2023-03-31 | $0.18 |
| 2022-12-31 | $0.03 |
| 2022-09-30 | $0.13 |
| 2022-06-30 | $0.09 |
| 2022-03-31 | $0.05 |
| 2021-12-31 | $0.15 |
| 2021-09-30 | $0.17 |
| 2021-06-30 | $0.19 |
| 2021-03-31 | $0.15 |
| 2020-12-31 | $0.39 |
| 2020-09-30 | $0.05 |
| 2020-06-30 | $-0.01 |
| 2020-03-31 | $0.04 |
| 2019-12-31 | $0.39 |
| 2019-09-30 | $-1.10 |
| 2019-06-30 | $0.29 |
| 2019-03-31 | $0.01 |
| 2018-12-31 | $0.00 |
| 2018-09-30 | $-0.20 |
| 2018-06-30 | $0.00 |
| 2017-12-31 | $0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $1.875B | $1.167B |
| Progyny Inc. is a fertility benefits management company. It specializes in fertility and family building benefits solutions. Progyny Inc. is based in New York, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $141.538B | 26.55 |
| Elevance Health (ELV) | United States | $93.196B | 12.03 |
| CVS Health (CVS) | United States | $80.632B | 10.02 |
| Cencora (COR) | United States | $56.777B | 19.75 |
| DiDi Global (DIDIY) | China | $22.309B | 33.86 |
| Natera (NTRA) | United States | $21.101B | 0.00 |
| BioMerieux (BMXMF) | France | $15.355B | 0.00 |
| Solventum (SOLV) | United States | $12.924B | 13.68 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.447B | 0.00 |
| CochLear (CHEOY) | Australia | $11.597B | 0.00 |
| Revvity (RVTY) | United States | $11.030B | 18.98 |
| ICON (ICLR) | Ireland | $10.666B | 9.92 |
| Viatris (VTRS) | United States | $10.422B | 3.58 |
| Doximity (DOCS) | United States | $9.895B | 46.09 |
| Avantor (AVTR) | United States | $9.179B | 13.34 |
| Medpace Holdings (MEDP) | United States | $8.813B | 23.41 |
| HealthEquity (HQY) | United States | $8.752B | 43.06 |
| Sonic Healthcare (SKHHY) | Australia | $8.273B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.050B | 13.81 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| Bausch + Lomb (BLCO) | Canada | $4.153B | 24.48 |
| BrightSpring Health Services (BTSG) | United States | $4.151B | 38.42 |
| Sotera Health (SHC) | United States | $3.639B | 20.68 |
| Alignment Healthcare (ALHC) | United States | $3.102B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.973B | 38.67 |
| Concentras Parent (CON) | United States | $2.889B | 16.70 |
| Organon (OGN) | United States | $2.277B | 2.42 |
| Ardent Health Partners (ARDT) | United States | $2.164B | 9.23 |
| GeneDx Holdings (WGS) | United States | $2.058B | 79.24 |
| Premier (PINC) | United States | $1.902B | 14.44 |
| PACS (PACS) | United States | $1.606B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.418B | 28.36 |
| Pediatrix Medical (MD) | United States | $1.302B | 9.91 |
| Teladoc Health (TDOC) | United States | $1.288B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.089B | 0.00 | |
| Agilon Health (AGL) | United States | $1.027B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
| CareDx (CDNA) | United States | $0.988B | 15.43 |
| Nutex Health (NUTX) | United States | $0.986B | 14.90 |
| AMN Healthcare Services Inc (AMN) | United States | $0.878B | 8.22 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| Embecta (EMBC) | United States | $0.718B | 4.84 |
| InnovAge Holding (INNV) | United States | $0.572B | 0.00 |
| Enhabit (EHAB) | United States | $0.537B | 44.21 |
| Auna S.A (AUNA) | Luxembourg | $0.518B | 11.67 |
| LifeMD (LFMD) | United States | $0.484B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.484B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.429B | 0.00 |
| SBC Medicals (SBC) | United States | $0.368B | 0.00 |
| Beauty Health (SKIN) | United States | $0.212B | 0.00 |
| Oncology Institute (TOI) | United States | $0.210B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.210B | 0.00 |
| DocGo (DCGO) | United States | $0.142B | 23.17 |
| KindlyMD (KDLY) | United States | $0.092B | 0.00 |
| So-Young (SY) | China | $0.087B | 0.00 |
| OncoCyte (OCX) | United States | $0.084B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.080B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.067B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Biodesix (BDSX) | United States | $0.040B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.037B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.031B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.031B | 0.00 |
| ModivCare (MODV) | United States | $0.014B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |